肿瘤与癌症研究, Cancer Research
肿瘤研究相关试剂材料：肿瘤干细胞、血管生成、抗肿瘤药物、癌症标记物和抗体、癌症代谢、致癌物、细胞分析、化学预防剂、细胞因子 & 生长因子、癌症相关的酶、多药耐药性、肿瘤生长调节等。
浏览为
排序由
显示 每页
人类sRank受体，sRank Receptor human [ODAR, TNFRSF11A, TRANCE Receptor]；recombinant, expressed in E. coli, ≥98% (SDS-PAGE), ≥98% (HPLC), suitable for cell culture
SRP3160
![图片 人类sRank受体，sRank Receptor human [ODAR, TNFRSF11A, TRANCE Receptor]；recombinant, expressed in E. coli, ≥98% (SDS-PAGE), ≥98% (HPLC), suitable for cell culture](https://www.bszh.cn/images/thumbs/default-image_415.png "显示明细 人类sRank受体，sRank Receptor human [ODAR, TNFRSF11A, TRANCE Receptor]；recombinant, expressed in E. coli, ≥98% (SDS-PAGE), ≥98% (HPLC), suitable for cell culture")
别名：ODAR (osteoclast differentiation and activation receptor), TNFRSF11A, TRANCE Receptor；NACRES NA.32
¥4,396.12
sRank Ligand from rat，[OPGL, TNFSF11, TRANCE]；recombinant, expressed in E. coli, ≥98% (SDS-PAGE), ≥98% (HPLC), suitable for cell culture
SRP3254
别名：OPGL, TNFSF11, TRANCE (TNF-related activation-induced cytokine), soluble Receptor Activator of NFkB Ligand； NACRES NA.32
¥4,396.12
sRANKL human，[ODF, TNFSF11, TRANCE]；recombinant, expressed in E. coli, ≥98% (SDS-PAGE), ≥98% (HPLC), suitable for cell culture
SRP3161
别名：NFkB配体可溶性受体激活剂；TRANCE（TNF 相关活化诱导细胞因子）；破骨细胞分化因子；ODF (Osteoclast differentiation factor), TNFSF11, TRANCE (TNF-related activation-induced cytokine), soluble Receptor Activator of NFkB Ligand；NACRES NA.32
¥4,396.12
sTNF-receptor Type I human，[TNF-R55, TNFAR, TNFRSF1A]；recombinant, expressed in E. coli, ≥98% (SDS-PAGE), ≥98% (HPLC), suitable for cell culture
SRP3162
别名：Soluble Tumor Necrosis Factor type I, TNF-R55, TNFAR, TNFRSF1A；NACRES NA.32
¥4,396.12
sTNF-receptor Type II human，[TNFR75, TNFRSF1B, p75]；recombinant, expressed in E. coli, ≥98% (SDS-PAGE), ≥98% (HPLC), suitable for cell culture
SRP3163
别名：Soluble Tumor Necrosis Factor type II, TNFR75, TNFRSF1B, p75；NACRES NA.32
¥4,396.12
sTRAIL Receptor-1 (DR4) human，[Apo2, DR4, TNFRSF10A]；recombinant, expressed in E. coli, ≥98% (SDS-PAGE), ≥98% (HPLC), suitable for cell culture
SRP3164
别名：Apo2, DR4, TNFRSF10A, soluble TRAIL Receptor-1；可溶性肿瘤坏死因子相关的凋亡诱导配体受体1（sTRAIL-R1）
¥4,396.12
sTRAIL Receptor-2 (DR5) human，[DR5, KILER, TNFRSF10B]；recombinant, expressed in E. coli, ≥98% (SDS-PAGE), ≥98% (HPLC), suitable for cell culture
SRP3165
别名：DR5, KILER, TNFRSF10B, soluble TRAIL Receptor-2；可溶性肿瘤坏死因子相关的凋亡诱导配体受体2（sTRAIL-R2）
¥4,396.12
TACI human，[TNFRSF13B]；recombinant, expressed in E. coli, ≥98% (SDS-PAGE), ≥98% (HPLC), suitable for cell culture
SRP3166
别名：TNFRSF13B；Transmembrane activator and CAML interactor；NACRES NA.32
¥4,550.23
TL-1A human，[TNFSF15, VEGI]；recombinant, expressed in E. coli, ≥98% (SDS-PAGE), ≥98% (HPLC), suitable for cell culture
SRP3175
TL-1A属于配体的TNF超家族。 重组人TL-1A是具有194个氨基酸残基的22.0kDa多肽。NACRES: NA.32
¥4,396.12
TLR-3 human，recombinant, expressed in HEK 293 cells, ≥95% (SDS-PAGE), ≥95% (HPLC), suitable for cell culture
SRP3176
别名：CD283 antigen；Toll-like receptor 3；NACRES NA.32
TLR-3是与微生物病原体和双链RNA（dsRNA）病毒结合并发出信号的I型单程受体。 重组人TLR-3是77.0kDa的糖蛋白，其包含681个残基，其包含TLR-3细胞外结构域。
TLR-3是与微生物病原体和双链RNA（dsRNA）病毒结合并发出信号的I型单程受体。 重组人TLR-3是77.0kDa的糖蛋白，其包含681个残基，其包含TLR-3细胞外结构域。
¥5,350.00
TRAIL from mouse，[Apo2 Ligand, TL2, TNFSF10]；recombinant, expressed in E. coli, ≥95% (SDS-PAGE), ≥95% (HPLC), suitable for cell culture
SRP3237
![图片 TRAIL from mouse，[Apo2 Ligand, TL2, TNFSF10]；recombinant, expressed in E. coli, ≥95% (SDS-PAGE), ≥95% (HPLC), suitable for cell culture](https://www.bszh.cn/images/thumbs/0017515_trail-from-mouseapo2-ligand-tl2-tnfsf10recombinant-expressed-in-e-coli-95-sds-page-95-hplc-suitable-_415.webp "显示明细 TRAIL from mouse，[Apo2 Ligand, TL2, TNFSF10]；recombinant, expressed in E. coli, ≥95% (SDS-PAGE), ≥95% (HPLC), suitable for cell culture")
别名：Apo2 Ligand, TL2, TNF-related apoptosis-inducing Ligand, TNFSF10；NACRES NA.32
¥4,396.12
TWEAK Receptor human，[FGF-inducible 14, TNFRSF12A]；recombinant, expressed in E. coli, ≥98% (SDS-PAGE), ≥98% (HPLC), suitable for cell culture
SRP3180
别名：FGF-inducible 14, TNF-related weak inducer of apoptosis receptor, TNFRSF12A；NACRES NA.32
¥4,396.12
